InsiderFlow

FibroBiologics, Inc. Common Stock

$0.31-0.03 (-8.26%)

Prev Close

$0.34

Open

$0.34

High

$0.39

Low

$0.31

Volume

767.7K

Market Cap

$16.8M

P/E

Div Yield

Over the past 12 months, insider activity at FibroBiologics, Inc. Common Stock (FBLG) has been exclusively buying, with 6 insider purchases totaling $168.3K and 0 insider sales totaling $0.00. The most recent insider transaction was by Khoja Hamid (officer: Chief Scientific Officer), who purchased $22.8K worth of shares on Mar 5, 2026. FibroBiologics, Inc. Common Stock operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $16.8M.

Buys (12M)

6

$168.3K

Sells (12M)

0

$0.00

Net Activity

Net Buyer

$168.3K

Active Insiders

4

last 12 mo

FBLG Price Chart

FBLG Insider Trading Activity

DateInsiderRoleTypeSharesAvg PriceValueShares After
Mar 5, 2026Khoja Hamidofficer: Chief Scientific OfficerBuy60,000$0.38$22.8K61,250
Mar 4, 2026O'HEERON PETEdirector, officer: CHIEF EXECUTIVE OFFICERBuy103,000$0.38$39.1K5,958,150
Mar 3, 2026Davis Jasonofficer: Chief Financial OfficerBuy70,000$0.41$29.0K70,000
Mar 2, 2026GARCIA RUBEN Aofficer: General CounselBuy40,000$0.33$13.1K180,000
Dec 11, 2025GARCIA RUBEN AGeneral CounselBuy140,000$0.34$47.6K0
May 27, 2025Khoja HamidChief Scientific OfficerBuy20,000$0.84$16.8K0

FBLG Insider Buying Activity

The following table shows recent insider purchases of FibroBiologics, Inc. Common Stock (FBLG) stock reported via SEC Form 4 filings.

DateInsiderRoleTypeSharesAvg PriceValueShares After
Mar 5, 2026Khoja Hamidofficer: Chief Scientific OfficerBuy60,000$0.38$22.8K61,250
Mar 4, 2026O'HEERON PETEdirector, officer: CHIEF EXECUTIVE OFFICERBuy103,000$0.38$39.1K5,958,150
Mar 3, 2026Davis Jasonofficer: Chief Financial OfficerBuy70,000$0.41$29.0K70,000
Mar 2, 2026GARCIA RUBEN Aofficer: General CounselBuy40,000$0.33$13.1K180,000
Dec 11, 2025GARCIA RUBEN AGeneral CounselBuy140,000$0.34$47.6K0
May 27, 2025Khoja HamidChief Scientific OfficerBuy20,000$0.84$16.8K0

FBLG Insider Selling Activity

The following table shows recent insider sales of FibroBiologics, Inc. Common Stock (FBLG) stock reported via SEC Form 4 filings.

No insider selling activity found for FBLG in the last 12 months.

FBLG Insiders

Khoja Hamid

officer: Chief Scientific Officer

Bought $22.8K
2 tradesLast: Mar 4, 2026
O'HEERON PETE

director, officer: CHIEF EXECUTIVE OFFICER

Bought $39.1K
6 tradesLast: Mar 4, 2026
Davis Jason

officer: Chief Financial Officer

Bought $29.0K
1 tradesLast: Mar 2, 2026
GARCIA RUBEN A

officer: General Counsel

Bought $13.1K
1 tradesLast: Feb 27, 2026
GARCIA RUBEN A

General Counsel

Bought $47.6K
1 tradesLast: Dec 11, 2025
Khoja Hamid

Chief Scientific Officer

Bought $16.8K
1 tradesLast: May 27, 2025